Carmat SA
PAR:ALCAR

Watchlist Manager
Carmat SA Logo
Carmat SA
PAR:ALCAR
Watchlist
Price: 1.04 EUR -1.89% Market Closed
Market Cap: 44.1m EUR
Have any thoughts about
Carmat SA?
Write Note

Carmat SA
Change in Working Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Carmat SA
Change in Working Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
Carmat SA
PAR:ALCAR
Change in Working Capital
-€6.7m
CAGR 3-Years
34%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Edap Tms SA
NASDAQ:EDAP
Change in Working Capital
€520k
CAGR 3-Years
N/A
CAGR 5-Years
-7%
CAGR 10-Years
-4%
Biomerieux SA
PAR:BIM
Change in Working Capital
-€339.5m
CAGR 3-Years
-33%
CAGR 5-Years
-30%
CAGR 10-Years
-68%
Visiomed Group SA
PAR:ALVMG
Change in Working Capital
-€55k
CAGR 3-Years
75%
CAGR 5-Years
N/A
CAGR 10-Years
21%
Theradiag SA
PAR:ALTER
Change in Working Capital
-€220k
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amplitude Surgical SA
PAR:AMPLI
Change in Working Capital
-€8.9m
CAGR 3-Years
-31%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
No Stocks Found

Carmat SA
Glance View

Market Cap
44.1m EUR
Industry
Health Care

Carmat SA engages in the developing of implantable orthotropic and biocompatible artificial heart. The company is headquartered in Velizy-Villacoublay, Ile-De-France and currently employs 160 full-time employees. The company went IPO on 2010-07-07. The firm is developing an orthotopic and biocompatible artificial heart which works like a natural heart and which is hydraulically activated. The firm formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels and Blood Institute, Laboratoire de Recherche Biochirurgicale and others. As of December 31, 2011, a company MATRA DEFENSE held a 30.57% stake in the Company’s shareholdings.

ALCAR Intrinsic Value
4.98 EUR
Undervaluation 79%
Intrinsic Value
Price

See Also

What is Carmat SA's Change in Working Capital?
Change in Working Capital
-6.7m EUR

Based on the financial report for Jun 30, 2024, Carmat SA's Change in Working Capital amounts to -6.7m EUR.

What is Carmat SA's Change in Working Capital growth rate?
Change in Working Capital CAGR 3Y
34%

Over the last year, the Change in Working Capital growth was -47%. The average annual Change in Working Capital growth rates for Carmat SA have been 34% over the past three years .

Back to Top